Assembly biosciences reports inducement grants under nasdaq listing rule 5635(c)(4)

South san francisco, calif., jan. 07, 2022 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis b virus (hbv) and other viral diseases, today announced grants of stock options to two new employees to purchase an aggregate of 7,000 shares of the company's common stock with an exercise price of $2.45 per share, the closing price of assembly bio's common stock on january 3, 2022. the stock options were granted as material inducements to the new employees to accept the company's offers of employment.
ASMB Ratings Summary
ASMB Quant Ranking